{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:56:12Z","timestamp":1793318172614,"version":"4.5.0"},"reference-count":81,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hungarian Research, Development and Innovation Office","award":["OTKA 124343"],"award-info":[{"award-number":["OTKA 124343"]}]},{"name":"Hungarian Research, Development and Innovation Office","award":["2020-1.1.6-J\u00d6V\u00d6-2021-00003"],"award-info":[{"award-number":["2020-1.1.6-J\u00d6V\u00d6-2021-00003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>In recent years, tremendous efforts have been devoted to characterizing the inflammatory processes in chronic obstructive pulmonary disease (COPD) in order to provide more personalized treatment for COPD patients. While it has proved difficult to identify COPD-specific inflammatory pathways, the distinction between eosinophilic and non-eosinophilic airway inflammation has gained clinical relevance. Evidence has shown that sputum eosinophil counts are increased in a subset of COPD patients and that these patients are more responsive to oral or inhaled corticosteroid therapy. Due to feasibility issues associated with sputum cell profiling in daily clinical practice, peripheral blood eosinophil counts and fractional exhaled nitric oxide levels have been evaluated as surrogate biomarkers for assessing the extent of airway eosinophilia in COPD patients, both in stable disease and acute exacerbations. The diagnostic value of these markers is not equivalent and depends heavily on the patient\u2019s condition at the time of sample collection. Additionally, the sensitivity and specificity of these tests may be influenced by the patient\u2019s maintenance treatment. Overall, eosinophilic COPD may represent a distinct disease phenotype that needs to be further investigated in terms of prognosis and treatment outcomes.<\/jats:p>","DOI":"10.3390\/biomedicines10092128","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T21:25:18Z","timestamp":1661894718000},"page":"2128","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Blood Eosinophils and Exhaled Nitric Oxide: Surrogate Biomarkers of Airway Eosinophilia in Stable COPD and Exacerbation"],"prefix":"10.3390","volume":"10","author":[{"given":"Balazs","family":"Antus","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, National Koranyi Institute of Pulmology, Koranyi Frigyes Ut 1, 1121 Budapest, Hungary"},{"name":"Department of Pulmonology, National Koranyi Institute of Pulmology, Koranyi Frigyes Ut 1, 1121 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-5166","authenticated-orcid":false,"given":"Imre","family":"Barta","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, National Koranyi Institute of Pulmology, Koranyi Frigyes Ut 1, 1121 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"Barnes","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccm.2020.06.007","article-title":"Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations","volume":"41","author":"Ritchie","year":"2020","journal-title":"Clin. Chest Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/resp.14041","article-title":"Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact","volume":"26","author":"MacLeod","year":"2021","journal-title":"Respirology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jaci.2018.04.020","article-title":"Biologics and chronic obstructive pulmonary disease","volume":"141","author":"Pavord","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2500\/aap.2016.37.3996","article-title":"Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators","volume":"37","author":"Brightling","year":"2016","journal-title":"Allergy Asthma Proc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","article-title":"Inflammatory endotypes in COPD","volume":"74","author":"Barnes","year":"2019","journal-title":"Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/thoraxjnl-2019-214484","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits","volume":"75","author":"Mathioudakis","year":"2020","journal-title":"Thorax"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: Predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: Identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","article-title":"Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema","volume":"115","author":"Fujimoto","year":"1999","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: A randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12931-017-0570-5","article-title":"Blood and sputum eosinophils in COPD; relationship with bacterial load","volume":"18","author":"Kolsum","year":"2017","journal-title":"Respir. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1007\/s10753-013-9653-8","article-title":"Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide","volume":"36","author":"Soter","year":"2013","journal-title":"Inflammation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5603\/ARM.a2017.0045","article-title":"Eosinophilic COPD\u2014A distinct phenotype of the disease","volume":"85","author":"Tworek","year":"2017","journal-title":"Adv. Respir. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.09-2090","article-title":"Exhaled nitric oxide in pulmonary diseases: A comprehensive review","volume":"138","author":"Barnes","year":"2010","journal-title":"Chest"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.2147\/COPD.S165780","article-title":"Exhaled nitric oxide in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"13","author":"Lu","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.201703-0592ED","article-title":"Predicting corticosteroid response in chronic obstructive pulmonary disease. Blood eosinophils gain momentum","volume":"196","author":"Singh","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/17476348.2021.2011219","article-title":"Blood eosinophils in COPD: Friend or foe?","volume":"16","author":"Papaporfyriou","year":"2022","journal-title":"Expert. Rev. Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1900651","DOI":"10.1183\/13993003.00651-2019","article-title":"Airway inflammation in COPD: Progress to precision medicine","volume":"54","author":"Brightling","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09059180.00004211","article-title":"Beyond corticosteroids: Future prospects in the management of inflammation in COPD","volume":"20","author":"Roche","year":"2011","journal-title":"Eur. Respir. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00281-016-0561-5","article-title":"COPD immunopathology","volume":"38","author":"Caramori","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/path.5364","article-title":"Recent advances in chronic obstructive pulmonary disease pathogenesis: From disease mechanisms to precision medicine","volume":"250","author":"Brandsma","year":"2020","journal-title":"J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12931-019-1017-y","article-title":"The pathology of small airways disease in COPD: Historical aspects and future directions","volume":"20","author":"Higham","year":"2019","journal-title":"Respir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/092986732205150112104411","article-title":"Oxidative stress in COPD: Molecular background and clinical monitoring","volume":"22","author":"Antus","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Barnes, P.J. (2022). Oxidative Stress in chronic obstructive pulmonary disease. Antioxidants, 11.","DOI":"10.3390\/antiox11050965"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nrrheum.2014.98","article-title":"Eosinophils in vasculitis: Characteristics and roles in pathogenesis","volume":"10","author":"Khoury","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/thoraxjnl-2020-215167","article-title":"Eosinophilic inflammation in COPD: From an inflammatory marker to a treatable trait","volume":"76","author":"David","year":"2021","journal-title":"Thorax"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.162.5.9910112","article-title":"Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease","volume":"162","author":"Papi","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: An analysis of the SPIROMICS cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: A randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2147\/COPD.S257965","article-title":"Predictive value of exhaled nitric oxide and blood eosinophil count in the assessment of airway eosinophilia in COPD","volume":"15","author":"Antus","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"00543","DOI":"10.1183\/23120541.00543-2020","article-title":"Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses","volume":"7","author":"Csoma","year":"2021","journal-title":"ERJ. Open Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Casolari, P.; Caramori, G.; Fabbri, L.M.; Johnston, S.L. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1600965","DOI":"10.1183\/13993003.00965-2016","article-title":"A European Respiratory Society technical standard: Exhaled biomarkers in lung disease","volume":"49","author":"Barnes","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.rmed.2010.06.005","article-title":"Assessment of exhaled nitric oxide by a new hand-held device","volume":"104","author":"Antus","year":"2010","journal-title":"Respir. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1465-9921-7-67","article-title":"Performance of a new hand-held device for exhaled nitric oxide measurement in adults and children","volume":"7","author":"Alving","year":"2006","journal-title":"Respir. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1398-9995.2007.01475.x","article-title":"Reliability of a new hand-held device for the measurement of exhaled nitric oxide","volume":"62","author":"Khalili","year":"2007","journal-title":"Allergy"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/thx.2005.056093","article-title":"Exhaled nitric oxide measurements: Clinical application and interpretation","volume":"61","author":"Taylor","year":"2006","journal-title":"Thorax"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1183\/09031936.98.12040816","article-title":"Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COPD","volume":"12","author":"Rutgers","year":"1998","journal-title":"Eur. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thx.54.7.572","article-title":"Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease","volume":"54","author":"Corradi","year":"1999","journal-title":"Thorax"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/thx.53.10.881","article-title":"Endogenous nitric oxide in patients with stable COPD: Correlates with severity of disease","volume":"53","author":"Clini","year":"1998","journal-title":"Thorax"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"036017","DOI":"10.1088\/1752-7163\/aac10a","article-title":"Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease","volume":"12","author":"Kelemen","year":"2018","journal-title":"J. Breath. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00408-014-9591-8","article-title":"Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD","volume":"192","author":"Chou","year":"2014","journal-title":"Lung"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2147\/COPD.S115378","article-title":"Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD","volume":"11","author":"Chen","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.2147\/COPD.S167600","article-title":"Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap","volume":"13","author":"Takayama","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1164\/rccm.200905-0685OC","article-title":"Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide","volume":"180","author":"Dummer","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1183\/09031936.05.00047305","article-title":"Effects of exacerbations and seasonality on exhaled nitric oxide in COPD","volume":"26","author":"Bhowmik","year":"2005","journal-title":"Eur. Respir. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1399-3003.1999.14c08.x","article-title":"Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Agusti","year":"1999","journal-title":"Eur. Respir. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1440-1843.2010.01711.x","article-title":"Relationship between exhaled nitric oxide and treatment response in COPD patients with exacerbations","volume":"15","author":"Antus","year":"2010","journal-title":"Respirology"},{"key":"ref_52","unstructured":"(2022, June 10). Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available online: https:\/\/goldcopd.org\/."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1556\/APhysiol.100.2013.016","article-title":"Relationship between exhaled nitric oxide and the frequency of severe acute exacerbation of COPD: 3-year follow-up","volume":"100","author":"Antus","year":"2013","journal-title":"Acta. Physiol. Hung."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/COPD.S134998","article-title":"Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD","volume":"12","author":"Gao","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1164\/ajrccm.164.6.2012139","article-title":"Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: Effects of inhaled beclomethasone","volume":"164","author":"Ferreira","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.rmed.2004.12.008","article-title":"The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease","volume":"99","author":"Zietkowski","year":"2005","journal-title":"Respir. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1159\/000106379","article-title":"Nitric oxide and exhaled breath nitrite\/nitrates in chronic obstructive pulmonary disease patients","volume":"74","author":"Liu","year":"2007","journal-title":"Respiration"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/crj.12518","article-title":"Response of exhaled nitric oxide to inhaled corticosteroids in patients with stable COPD: A systematic review and meta-analysis","volume":"12","author":"Lim","year":"2018","journal-title":"Clin. Respir. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.2147\/COPD.S100338","article-title":"Peripheral blood eosinophils: A surrogate marker for airway eosinophilia in stable COPD","volume":"11","author":"Negewo","year":"2016","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: A post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2213-2600(18)30137-1","article-title":"The association between blood eosinophils and risk and treatment outcome in COPD is not dichotomised","volume":"6","author":"Pascoe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-2600(19)30190-0","article-title":"Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: Analysis of the IMPACT trial","volume":"7","author":"Pascoe","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e000151","DOI":"10.1136\/bmjresp-2016-000151","article-title":"Effect of inhaled corticosteroids on blood eosinophil count in steroid-na\u00efve patients with COPD","volume":"3","author":"Kreindler","year":"2016","journal-title":"BMJ. Open Respir. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1902119","DOI":"10.1183\/13993003.02119-2019","article-title":"Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD","volume":"55","author":"Mathioudakis","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15412555.2017.1313827","article-title":"Stability of blood eosinophil count in patients with COPD in the UK Clinical Practice Research Datalink","volume":"14","author":"Landis","year":"2017","journal-title":"J. Chronic Obstr. Pulm. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1164\/rccm.201701-0009LE","article-title":"Stability of blood eosinophils in patients with chronic obstructive pulmonary disease and in control subjects, and the impact of sex, age, smoking, and baseline counts","volume":"195","author":"Oshagbemi","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2147\/COPD.S165909","article-title":"Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort","volume":"13","author":"Greulich","year":"2018","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: Prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1800427","DOI":"10.1183\/13993003.00427-2018","article-title":"The reproducibility of COPD blood eosinophil counts","volume":"52","author":"Southworth","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1701162","DOI":"10.1183\/13993003.01162-2017","article-title":"Prevalence of persistent blood eosinophilia: Relation to outcomes in patients with COPD","volume":"50","author":"Casanova","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: A randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1183\/09031936.00062614","article-title":"Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis","volume":"44","author":"Bafadhel","year":"2014","journal-title":"Eur. Respir. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.rmed.2017.07.064","article-title":"Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD","volume":"131","author":"Prins","year":"2017","journal-title":"Respir. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.chest.2016.10.003","article-title":"Eosinophils in COPD exacerbations are associated with increased readmissions","volume":"151","author":"Couillard","year":"2017","journal-title":"Chest"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chest.2019.02.406","article-title":"Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD","volume":"156","author":"MacDonald","year":"2019","journal-title":"Chest"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12931-020-01482-1","article-title":"Blood eosinophils as a biomarker of future COPD exacerbation risk: Pooled data from 11 clinical trials","volume":"21","author":"Singh","year":"2020","journal-title":"Respir. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1800616","DOI":"10.1183\/13993003.00616-2018","article-title":"Combined value of exhaled nitric oxide and blood eosinophils in chronic airway disease: The Copenhagen General Population Study","volume":"52","author":"Afzal","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2147\/COPD.S273422","article-title":"The value of inflammatory biomarkers in differentiating asthma-COPD overlap from COPD","volume":"15","author":"Li","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1802058","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: A new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur. Respir. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/COPD.S330817","article-title":"Treatable traits in COPD\u2014A proposed approach","volume":"16","author":"Cardoso","year":"2021","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2128\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:35Z","timestamp":1760142035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":81,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["biomedicines10092128"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10092128","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}